[go: up one dir, main page]

GB9716345D0 - Therapeutic compounds - Google Patents

Therapeutic compounds

Info

Publication number
GB9716345D0
GB9716345D0 GBGB9716345.5A GB9716345A GB9716345D0 GB 9716345 D0 GB9716345 D0 GB 9716345D0 GB 9716345 A GB9716345 A GB 9716345A GB 9716345 D0 GB9716345 D0 GB 9716345D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic compounds
therapeutic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9716345.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Priority to GBGB9716345.5A priority Critical patent/GB9716345D0/en
Publication of GB9716345D0 publication Critical patent/GB9716345D0/en
Priority to PCT/GB1998/002289 priority patent/WO1999006400A1/fr
Priority to AU85520/98A priority patent/AU8552098A/en
Pending legal-status Critical Current

Links

GBGB9716345.5A 1997-08-01 1997-08-01 Therapeutic compounds Pending GB9716345D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9716345.5A GB9716345D0 (en) 1997-08-01 1997-08-01 Therapeutic compounds
PCT/GB1998/002289 WO1999006400A1 (fr) 1997-08-01 1998-07-30 Derives de pyrazoloquinolinone utilises en tant qu'agonistes inverses du recepteur gaba alpha 5
AU85520/98A AU8552098A (en) 1997-08-01 1998-07-30 Pyrazoloquinolinone derivatives as gaba alpha 5 receptor inverse agonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9716345.5A GB9716345D0 (en) 1997-08-01 1997-08-01 Therapeutic compounds

Publications (1)

Publication Number Publication Date
GB9716345D0 true GB9716345D0 (en) 1997-10-08

Family

ID=10816865

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9716345.5A Pending GB9716345D0 (en) 1997-08-01 1997-08-01 Therapeutic compounds

Country Status (3)

Country Link
AU (1) AU8552098A (fr)
GB (1) GB9716345D0 (fr)
WO (1) WO1999006400A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2483728T3 (es) * 2007-06-08 2014-08-07 Dart Neuroscience (Cayman) Ltd Derivados terapéuticos de pirazolonafatiridina
US7863266B2 (en) * 2007-06-08 2011-01-04 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline urea derivatives
EP2188284A2 (fr) * 2007-08-14 2010-05-26 Novartis Ag Composés hétérocycliques tricycliques comme modulateurs du recepteur gaba
EP2188285A1 (fr) * 2007-08-14 2010-05-26 Novartis Ag Dérivés de pyrazoloquinoléine et de pyrazolonaphtyridine comme ligands gaba alpha
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
MX2014013881A (es) * 2012-05-16 2015-08-14 Archer Daniels Midland Co Emulsificante para solubilizar solventes polares en aceites y polioles.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0214092A1 (fr) * 1985-08-08 1987-03-11 Ciba-Geigy Ag Absorption d'aryl-2 pyrazoloquinoléines psychoactives sous forme d'une dispersion moléculaire solide dans la polyvinylpyrrolidone

Also Published As

Publication number Publication date
AU8552098A (en) 1999-02-22
WO1999006400A1 (fr) 1999-02-11

Similar Documents

Publication Publication Date Title
ZA983176B (en) Therapeutic compounds
GB9708484D0 (en) Therapeutic agents
GB9708945D0 (en) Therapeutic agents
GB9704948D0 (en) Therapeutic agents
GB9702524D0 (en) Therapeutic agents
ZA982368B (en) New therapeutic combinations
GB9711753D0 (en) Therapeutic agents
GB9713707D0 (en) Therapeutic agents
GB9715977D0 (en) Therapeutic agents
GB9711114D0 (en) Therapeutic agents
GB9600143D0 (en) Therapeutic compounds
GB9700939D0 (en) Therapy
GB9702392D0 (en) Therapeutic agents
GB9808665D0 (en) Therapeutic compounds
GB9700555D0 (en) Therapeutic agents
GB9716345D0 (en) Therapeutic compounds
GB9824897D0 (en) Therapeutic compounds
GB9716347D0 (en) Therapeutic compounds
GB9716344D0 (en) Therapeutic compounds
GB9716463D0 (en) Therapeutic agents
GB9626450D0 (en) Therapeutic compounds
GB9808667D0 (en) Therapeutic compounds
GB9705401D0 (en) Therapeutic compounds
GB9716111D0 (en) Therapeutic compounds
GB9716457D0 (en) Therapeutic agents